Search for: "Anda Pharmaceuticals, Inc"
Results 381 - 400
of 607
Sort by Relevance
|
Sort by Date
12 Apr 2011, 9:37 pm
• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
5 Apr 2011, 2:35 pm
Par Pharmaceutical, Inc. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
25 Mar 2011, 8:29 pm
" Duramed Pharmaceuticals v. [read post]
17 Mar 2011, 7:47 am
Watson Pharmaceuticals Inc., et. al., 1-08-cv-00330 (DED March 11, 2011, Order) (Robinson, J.) [read post]
1 Mar 2011, 3:24 pm
., v Cobrek Pharmaceuticals Inc., (NDIL, Order 2/17/11), the relatively rare case of a Patentee requested stay was at issue. [read post]
1 Mar 2011, 3:24 pm
., v Cobrek Pharmaceuticals Inc., (NDIL, Order 2/17/11), the relatively rare case of a Patentee requested stay was at issue. [read post]
27 Feb 2011, 8:59 pm
Mylan Inc. et al. 1:11-cv-01285; filed February 23, 2010 in the Northern District of Illinois • Plaintiff: The Medicines Company • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.; Bioniche Pharma USA, LLC Infringement of U.S. [read post]
25 Feb 2011, 3:10 am
., v Cobrek Pharmaceuticals Inc., (NDIL, Order 2/17/11), the relatively rare case of a Patentee requested stay was at issue. [read post]
15 Feb 2011, 5:26 pm
: Ineos Healthcare v OHMI – Teva (Class 46) Androderm (Testosterone) – US: Watson settles with Promote Innovation in Androderm false marking suit (Patent Docs) Asacol (Mesalamine) – US: Roxane sanctioned in Asacol patent dispute with Medeva (Patent Docs) Detrol (Tolterodine) – US: Subsequent ANDA sponsor says Detrol LA patent has gotta go; But would a final court decision trigger 180-day exclusivity? [read post]
13 Feb 2011, 9:08 pm
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
10 Feb 2011, 5:35 pm
Another, subsequent ANDA sponsor, Sun Pharmaceuticals, obtained tentative approval for its ANDA No. 78-433 on March 4, 2008. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
6 Feb 2011, 9:34 pm
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
20 Jan 2011, 1:03 pm
Patent No. 7,101,574 ("the ‘574 patent") covering ANTARA (fenofibrate) Capsules, which is approved under NDA No. 21-695, and granted a Motion to Dismiss filed by defendants Ethypharm S.A., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
16 Jan 2011, 9:17 pm
Anchen Pharmaceuticals Inc. et al. 1:11-cv-00046; filed January 12, 2011 in the District Court of Delaware • Plaintiff: GlaxoSmithKline LLC • Defendants: Anchen Pharmaceuticals Inc.; Anchen Inc.; Banner Pharmacaps Inc. [read post]
30 Dec 2010, 5:48 am
Karst – Amphastar Pharmaceuticals Inc. [read post]
26 Dec 2010, 9:59 pm
Sandoz, Inc., the Federal Circuit vacated the entry of a consent judgment and an injunction by the District Court for the District of New Jersey, which enjoined Defendants-Appellants Sun Pharmaceutical Industries, Ltd. and Caraco Pharmaceutical Laboratories, Ltd. [read post]
22 Dec 2010, 3:01 am
-Florida (Patent Docs) FazaClo (Clozapine): US – Patent infringement complaint filed following a Paragraph IV certification: Mylan Pharmaceuticals Inc. v. [read post]
